Erschienen in:
01.06.2005 | Poster Presentation
Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
verfasst von:
V Drageset, JM Nesland, B Erikstein, E Skovlund, H Sommer, G Anker, E Wist, S Lundgren, J Bergh, G Kvalheim
Erschienen in:
Breast Cancer Research
|
Sonderheft 2/2005
Einloggen, um Zugang zu erhalten
Excerpt
The present study aimed to investigate the clinical relevance of minimal residual cancer in breast cancer patients before and after high-dose adjuvant chemotherapy with or without progenitor stem cell support. …